Harvey Pitt Explains the SEC Wells Notice Process

Nov. 29 (Bloomberg) -- Former SEC chairman Harvey Pitt explains the process following reception of a Wells Notice from the SEC and what is next for the commission after chairman Mary Schapiro steps down in December. He speaks on Bloomberg Television's "Market Makers."

Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
11:13 - Pfizer and Merck KGaA’s cancer immunotherapy won approval from U.S. regulators for patients with a rare form of skin cancer, and the companies plan to sell the drug for $13,000 a month. Merck KgaA CEO Stegfan Oschmann speaks on "Bloomberg Daybreak Europe." (Source: Bloomberg)
  • Aviva's Diebel Sees No Macro Impact From Healthcare Bill
  • Italy Junior Minister Sees Brexit as EU Opportunity
  • French Presidential Race Takes an Inflammatory Turn